Optase Ointment
FDA Label NDC 72972-003

The following Structured Product Label (SPL) was submitted to the FDA by Scope Health Inc for the product Optase (NDC 72972-003). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, keep out of reach of children, purpose, inactive ingredients, directions, warnings, uses, instructions for use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.